Choy H - Search Results

1

Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer.

Choy H, LaPorte K, Knill-Selby E, Mohr P, Shyr Y. Choy H, et al. Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):90-6. Semin Radiat Oncol. 1999. PMID: 10210546 Clinical Trial.

2

Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant.

MacRae R, Shyr Y, Johnson D, Choy H. MacRae R, et al. Among authors: choy h. Radiother Oncol. 2002 Jul;64(1):37-40. doi: 10.1016/s0167-8140(02)00151-2. Radiother Oncol. 2002. PMID: 12208573

3

Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer.

Kim DW, Shyr Y, Chen H, Akerley W, Johnson DH, Choy H. Kim DW, et al. Among authors: choy h. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1029-36. doi: 10.1016/j.ijrobp.2005.03.055. Int J Radiat Oncol Biol Phys. 2005. PMID: 15913910

4

Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer.

Kim DW, Shyr Y, Shaktour B, Akerley W, Johnson DH, Choy H. Kim DW, et al. Among authors: choy h. Lung Cancer. 2005 Nov;50(2):235-45. doi: 10.1016/j.lungcan.2005.05.020. Epub 2005 Jul 25. Lung Cancer. 2005. PMID: 16043262

5

Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.

Choy H, DeVore RF 3rd, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, LaPorte K, Johnson DH. Choy H, et al. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-21-S12-26. Semin Oncol. 1997. PMID: 9331115 Clinical Trial.

6

National survey on prophylactic cranial irradiation: differences in practice patterns between medical and radiation oncologists.

Cmelak AJ, Choy H, Shyr Y, Mohr P, Glantz MJ, Johnson DH. Cmelak AJ, et al. Among authors: choy h. Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):157-62. doi: 10.1016/s0360-3016(98)00557-4. Int J Radiat Oncol Biol Phys. 1999. PMID: 10219809

7

Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.

Choy H, Shyr Y, Cmelak AJ, Mohr PJ, Johnson DH. Choy H, et al. Cancer. 2000 Mar 15;88(6):1336-46. doi: 10.1002/(sici)1097-0142(20000315)88:6<1336::aid-cncr9>3.0.co;2-m. Cancer. 2000. PMID: 10717614

8

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).

Choy H, Devore RF 3rd, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, Johnson DH. Choy H, et al. Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):931-7. doi: 10.1016/s0360-3016(00)00420-x. Int J Radiat Oncol Biol Phys. 2000. PMID: 10863062 Clinical Trial.

9

Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial.

Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt PA, Slovis B, Laporte K, Shyr Y, Johnson DH. Choy H, et al. Lung Cancer. 2001 Dec;34(3):441-9. doi: 10.1016/s0169-5002(01)00279-3. Lung Cancer. 2001. PMID: 11714542 Clinical Trial.

10

Potential radiation-sensitizing effect of semisynthetic epothilone B in human lung cancer cells.

Kim JC, Kim JS, Saha D, Cao Q, Shyr Y, Choy H. Kim JC, et al. Among authors: choy h. Radiother Oncol. 2003 Sep;68(3):305-13. doi: 10.1016/s0167-8140(03)00200-7. Radiother Oncol. 2003. PMID: 13129641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

389 results

Search Page

Filters